Clinical Trials Logo

Clinical Trial Summary

A significant number of professionals subjected to high-risk situations have been infected by Covid-19, due to the lack of adequate respiratory protection equipment or poor marginal sealing adjustments. Then, the objective of this study is to determine if there are statistically significant differences in the level of respiratory protection of type IIR surgical face masks and filtering face masks, used with and without a peripheral sealing device, against the contagion of Covid-19 or other harmful biological agents. The proposed device is a thermoplastic resin ring composed of a reusable and biodegradable polylactic acid designed to be used in a healthcare environment. The individuals of the study will be submitted to qualitative fit tests, that meet current Ocupational Security and Health Administration (OSHA) standard. The mentioned qualitative fit test uses a sodium saccharin solution to evaluate the respiratory protection equipment in professionals in hospitals, emergency centers, and early childhood education centers.


Clinical Trial Description

The purpose of the research is to determine if there are statistically significant differences in the level of respiratory protection in situations of high risk against the contagion of Covid-19 or other harmful biological agents, in subjects who use filtering face pieces (FFP2) with or without a peripheral sealing device (AMS), Type IIR surgical face masks with or without a AMS, and subjects using the FFP2 filtering face mask simultaneously with the Type IIR surgical face mask. For this, a total of 210 individuals were selected from different environments in order to attain diversity, while controlling for representativeness bias. They were selected from the ADEMA University School - UIB, nursing staff from the Infectious Diseases Service at Son Espases University Hospital, 112 Emergency Service of the Autonomous Community of the Balearic Islands and the General Directorate of Planning and Centers of the Ministry of Education and Professional Training (Balearic Islands, Spain). Participants were assigned to one of the 5 groups and subgroups, after accepting their participation in the study voluntarily and freely by signing the consent form approved by the CEI-IB. To evaluate the adjustment of the respiratory protective equipment with and without the personalized peripheral sealing device (AMS), a sweet sensitivity test was performed with the 3M FT-10 Qualitative Fit-Test Kit (Saint Paul, Minnesota, USA), which complies with the current standards of the Occupational Security and Health Administration (OSHA) and according to the protocol described in Riutord-Sbert et al. (2021). During the qualitative fit test, a total of seven mobility exercises of 60 seconds each were performed, and the nebulizer was squeezed, every 30 seconds: Phase 1 - Normal breathing Phase 2 - Slow and deep breathing Phase 3 - Breathing whilst moving the head to both sides Phase 4 - Breathing whilst moving the head up and down Phase 5 - Breathing spelling the alphabet Phase 6 - Breathing whilst moving up and down from the waist Phase 7 - Normal breathing If the fit test was completed within 7 minutes without the individual having detected the sweet taste, the seal was considered optimal or adequate and the experiment was graded as APPROVED. If the subject detected the sweet test before seven minutes, the adjustment was considered inadequate and was scored as FAILED, noting the time it took to detect the sweet taste as established in the protocol of the 3M FT-10 Fit test (Riutord-Sbert et al. 2021). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05079308
Study type Interventional
Source University of the Balearic Islands
Contact
Status Completed
Phase N/A
Start date March 1, 2021
Completion date August 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Active, not recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3